Most Admired Corporate Dealmaker winner Abbott paid a high premium for Piramal's generic-drugs unit but now ranks No. 1 in India's $8 billion pharma industry.
Deal Video | December 6, 2010
Tags:. .dealmaker. .pharma. .abbott. .acquisition. .admired
Abbott Acquisition Admired Billion Dealmaker Paid Pharma Premium